Cessation of clinical disease and spirochete shedding after tiamulin treatment in pigs experimentally infected with “Brachyspira hampsonii” |
| |
| Authors: | BL Wilberts PH Arruda HL Warneke KR Erlandson JM Hammer ER Burrough |
| |
| Institution: | 1. Department of Veterinary Pathology, Iowa State University, Ames, IA, USA;2. Department of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA, USA;3. Novartis Animal Health, Greensboro, NC, USA |
| |
| Abstract: | With the emergence of “Brachyspira hampsonii” associated with swine dysentery in North America, identification of effective treatments and interventions is a pressing need. Denagard® (tiamulin hydrogen fumarate) Liquid Concentrate 12.5% is approved in the United States for treatment of dysentery caused by Brachyspira hyodysenteriae at 0.006% in the water. In this study, the effectiveness of tiamulin in resolving clinical disease, eliminating viable spirochete shedding, and reducing neutrophilic colitis following infection with either “B. hampsonii” or B. hyodysenteriae was evaluated. Seventy-eight 7-week-old crossbred pigs were divided into three groups sham-inoculated (n = 18), “B. hampsonii”-inoculated (n = 30), and B. hyodysenteriae-inoculated (n = 30)]. Each inoculum group was divided into three subgroups which received either 0.006% tiamulin, 0.018% tiamulin, or no medication. Both levels of tiamulin resolved clinical disease within 24 h of treatment initiation, eliminated spirochete shedding within 72 h of treatment initiation, and resolved and/or prevented histologic lesions in pigs infected with either Brachyspira spp. |
| |
| Keywords: | Brachyspira &ldquo Brachyspira hampsonii&rdquo Brachyspira hyodysenteriae Swine dysentery Tiamulin |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
